Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 6,942 Castle Biosciences, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 6,942 Castle Biosciences, Inc. shares at US$32.92 for US$229K under a trading plan, leaving 0 shares. Filed Nov 18, 2026 (Form 4).

Sold
6,942 shares
Price
US$32.92
Value
US$229K
Holding after
0 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockSale3,904US$32.920Direct
Nov 16, 2026Common StockSale1,642US$32.920Indirect
Nov 16, 2026Common StockSale1,396US$32.920Indirect

Source

Download original · View original at SEC

Related